I thought just the opposite of what you said. T
Post# of 30028
Posted On: 03/12/2016 3:19:08 PM
Re: All Aboard #22801
I thought just the opposite of what you said.
Where did they factor in the assets and revenue of AMDX and THI? While they talked about the deal, they only really talked about OvaDx to any extent.
The assumption is if you increase the OS x2, the value of the company increase x2 or greater. If not, why do the deal?
At the eod, it doesn't matter if it's $1.42, $2.97 or $5. If Roche buys OvaDx it doesn't matter.
Quote:
Then they go on to back up their price target and talk almost exclusively about the post-closing Avant.
Where did they factor in the assets and revenue of AMDX and THI? While they talked about the deal, they only really talked about OvaDx to any extent.
The assumption is if you increase the OS x2, the value of the company increase x2 or greater. If not, why do the deal?
At the eod, it doesn't matter if it's $1.42, $2.97 or $5. If Roche buys OvaDx it doesn't matter.
(7)
(1)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼